SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-21-106469
Filing Date
2021-08-16
Accepted
2021-08-16 17:12:54
Documents
2
Period of Report
2021-03-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2124781d1_8ka.htm 8-K/A 32430
2 EXHIBIT 99.1 tm2124781d1_ex99-1.htm EX-99.1 133871
  Complete submission text file 0001104659-21-106469.txt   167404
Mailing Address 2005 MARKET STREET, SUITE 2030 PHILADELPHIA PA 19103
Business Address 2005 MARKET STREET, SUITE 2030 PHILADELPHIA PA 19103 267-765-3222
IBERE PHARMACEUTICALS (Filer) CIK: 0001835205 (see all company filings)

IRS No.: 981564986 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-40119 | Film No.: 211179738
SIC: 6770 Blank Checks
Office of Real Estate & Construction